In this interview, NewsMedical speaks to DeNovix’s Dan Schieffer about the new app developed for CellDrop, and how it aims to revolutionize hepatocyte count for the drug discovery industry, and more.
After a handful of stumbles, argenx doubles down on pipeline-in-a-product strategy as it pitches investors
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS